Nisa Investment Advisors LLC raised its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 89.6% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 54,397 shares of the medical instruments supplier's stock after buying an additional 25,705 shares during the quarter. Nisa Investment Advisors LLC's holdings in DENTSPLY SIRONA were worth $1,041,000 as of its most recent filing with the SEC.
Other institutional investors have also recently modified their holdings of the company. UMB Bank n.a. raised its stake in DENTSPLY SIRONA by 430.3% during the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier's stock valued at $25,000 after buying an additional 753 shares in the last quarter. Capital Performance Advisors LLP purchased a new stake in shares of DENTSPLY SIRONA during the 3rd quarter worth about $27,000. MassMutual Private Wealth & Trust FSB boosted its stake in shares of DENTSPLY SIRONA by 648.4% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock worth $27,000 after acquiring an additional 1,232 shares in the last quarter. Kennebec Savings Bank acquired a new position in DENTSPLY SIRONA during the 3rd quarter worth $35,000. Finally, Van ECK Associates Corp bought a new stake in DENTSPLY SIRONA in the 3rd quarter valued at $42,000. 95.70% of the stock is currently owned by hedge funds and other institutional investors.
DENTSPLY SIRONA Stock Performance
Shares of XRAY traded down $0.48 during mid-day trading on Friday, hitting $19.84. The stock had a trading volume of 1,069,331 shares, compared to its average volume of 2,397,764. The firm has a market cap of $3.94 billion, a P/E ratio of -9.58, a PEG ratio of 1.87 and a beta of 0.96. DENTSPLY SIRONA Inc. has a 52 week low of $17.21 and a 52 week high of $35.36. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The business has a fifty day moving average price of $19.13 and a 200-day moving average price of $22.54.
DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, topping analysts' consensus estimates of $0.48 by $0.02. The firm had revenue of $951.00 million during the quarter, compared to analyst estimates of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business's quarterly revenue was up .4% on a year-over-year basis. During the same period in the previous year, the business posted $0.49 EPS. On average, equities research analysts expect that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.
DENTSPLY SIRONA Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, January 10th. Stockholders of record on Friday, December 27th were paid a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 3.23%. The ex-dividend date of this dividend was Friday, December 27th. DENTSPLY SIRONA's dividend payout ratio is currently -30.92%.
Analysts Set New Price Targets
Several brokerages recently commented on XRAY. Morgan Stanley decreased their price target on DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating on the stock in a research note on Tuesday, December 17th. Barrington Research reduced their price objective on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an "outperform" rating for the company in a research note on Friday, November 8th. UBS Group decreased their target price on DENTSPLY SIRONA from $35.00 to $27.00 and set a "buy" rating on the stock in a research report on Tuesday, December 3rd. StockNews.com lowered shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research report on Tuesday, November 19th. Finally, Jefferies Financial Group downgraded DENTSPLY SIRONA from a "buy" rating to a "hold" rating and dropped their price objective for the company from $30.00 to $20.00 in a research note on Thursday, January 23rd. Ten equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $26.33.
Read Our Latest Stock Analysis on XRAY
About DENTSPLY SIRONA
(
Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
See Also
Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
